| 2023 | | | |
| | HCV Case Presentation Form | Download Form |
| | Attestation Form to Prescribe HCV Direct Acting Antivirals without Prior Authorization | Download Form |
| August 28 | HCV Epidemiology; Elimination Efforts | |
| | | View Presentation by Dr. Risha Irvin |
| | | Watch Dr. Risha Irvin's Talk |
| | | Federal Implementation Plan for the United States for Viral Hepatitis |
| | | Fleurence-Collins HepC JAMA Viewpoint March 9, 2023 |
| | | CBS Morning Show, 8/4/23, with Dr. Collins talking about HCV Elimination Plan |
| September 11 | Brief Overview: Hawai`i State Elimination Efforts
HCV Diagnosis and Lab Evaluation | |
| | | Hep Free 2030: The Hawai`i Hepatitis Elimination Strategy |
| | | View Presentation by Thaddeus Pham |
| | | View Presentation by Marina Roytman |
| | | University of Washington Hepatitis C Online |
| | | DLS Test Directory: HCV Ab w/Rflx to RNA Quant & Geno |
| | | Liver Function Tests |
| | | Elevated Liver Enzymes |
| September 18 | HCV Treatment Options | |
| | | View Presentation by Naoky Tsai |
| | | AASLD Simplified HCV Treatment Algorithm 2020 |
| | | Liverpool Hep Drug Interaction Checker |
| September 25 | Pharmacy-based and Community-based HCV Care | |
| | | View Presentation by Melissa Bumgardner and Hiromi Saito |
| | | Resources for Cross Cultural Medicine (Links) |
| | | HRSA 340B Drug Pricing Program |
| | | American Liver Foundation - Financial Resources Guide (2018) |
| | | NeedyMeds |
| | | RxAssist |
| October 2 | Fibrosis Assessment | |
| | | View Presentation by Chuong Tran |
| | | FIB-4 Calculator |
| | | Fibroscan Reporting Guidelines Article and References |
| October 9 | Fatty Liver/ NASH | |
| | | View Presentation by Naoky Tsai |
| | | NAFLD Fibrosis Score |
| | | NAFLD Simulator |
| October 16 | HCC Surveillance; Patient Adherence and Follow-up | |
| | | View Presentation by Tomoki Sempokuya |
| | | GALAD Score Calculator |
| | | Article on What Makes a Good Screening Test |
| | | REACH-B Score for HCC (from mdcalc.com) |
| | | Interventional tools to improve medication adherence: review of literature |
| | | The challenge of patient adherence |
| | | Motivational Interviewing Techniques |
| | | Motivational Interviewing: Do's and Don'ts |
| October 23 | HCV Treatment with HBV and HIV Coinfection | |
| | | View Presentation by Marina Roytman |
| | | AASLD Recommended Management of DAA Treatment Interruptions |
| | | Immunize.org Ask the Experts about HBV |
| | | CMS Codes for HBV Screening |
| | | A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection |
| October 30 | HCV Among Special Populations (Houseless; Formerly Incarcerated; SUD) | |
| | | View Presentation by Anthony Martinez |
| | | Hepatitis C: State of Medicaid Access |
| | | CDC Recommendations for Hepatitis C Testing
Among Perinatally Exposed Infants and Children —
United States, 2023 |
| November 6 | Hepatitis Care Coordination | |
| | | View Presentation by Aaron Ruddick |
| | | NIH Book LiverTox: page on risperidone |
| November 13 | Standing Orders for Vaccines | |
| | | View Presentation by Dan Saltman |
| | | View Paij's story |
| | | Using Standing Orders for Administering Vaccines: What You Should Know |
| | | Immunize.org page on Standing Orders |
| | | Hepatitis B Vaccine Standing Order |
| | | Viral Hepatitis Guide for Primary Care Providers
Screening, Vaccination, and Billing, from CA Dept of Health |
| | | Hawaii Revised Statutes (325-033) regarding vaccines |
| | | CDC page on HBV Vaccine |
| | | Hawai`i Health and Harm Reduction Syringe Exchange Program |
| | | What you should know about Xylazine |
| November 20 | Participant Choice: Review HCV Indications, Contraindications and Treatment; Common Pitfalls, Approach to Treatment Interruptions, et al | |
| | | View Roundtable Presentation |
| | | AASLD's HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C |
| | | AASLD Simplified HCV Treatment Algorithm 2020 |
| | | AASLD Guidance on Incomplete Adherence |
| | | The Queen's Liver Center |
